CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an educational grant from Pfizer, Inc.
Target Audience: The intended audience for the activity is gastroenterologists, rheumatologists, primary care physicians, dermatologists, physician assistants, nurse practitioners, and other health care professionals involved in the treatment of patients with immune-mediated inflammatory diseases (IMIDs).
Learning Objective: Upon successful completion of this educational activity, participants should be better able to:
- Recognize the similarities and differences between biosimilars and reference biologic compounds.
- Examine the efficacy of biosimilars in the treatment of IMIDs, including the relative merit of switching from biologic therapy to biosimilars.
- Evaluate communication efforts that have improved patient knowledge about the use of biosimilars and encouraged their participation in the shared decision-making process.
Activity Chair:
Francis A. Farraye, MD, MSc
Director, Inflammatory Bowel Disease Center
Department of Gastroenterology and Hepatology
Mayo Clinic
Jacksonville, FL
Faculty
Shubha Bhat, PharmD, MS, BCACP
Clinical Pharmacist - Gastroenterology
Boston Medical Center
Boston, MA
Jonathan Kay, MD
Professor of Medicine and of Population and Quantitative Health Sciences
Timothy S. and Elaine L. Peterson Chair in Rheumatology
University of Massachusetts Medical School
University of Massachusetts Memorial Medical Center
Worcester, MA
Reviewer:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, March 31, 2020, through March 30, 2021.
How to Participate in This Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, view the activity, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.
Activity Chair and Faculty report the following relationship(s):
Shubha Bhat, PharmD, MS, BCACP
No relevant financial relationships to disclose.
Francis A. Farraye, MD, MSc
Consulting Fee: Bristol MyersSquibb, Braintree Laboratories, GlaxoSmithKline, Janssen, Pfizer, Takeda
Ownership Interest: Innovation Pharmaceuticals
Data Safety & Monitoring Board: Lilly, Theravance
Jonathan Kay, MD
Consulting Fee: Alvotech, Arena, Boehringer Ingelheim, Celltrion, GmbH, Merck, Mylan, Novartis, Samsung Bioepis, Sandoz, UCB
Contracted Research (Paid to Institution): Flexion, Gilead, Pfizer
Reviewer reports the following relationship(s):
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2020 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com